from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2009/vapB15

LFCtreatmentdescriptionclass of inhibitor

-0.580

Amikacinug/mL Amikacintranslation

-0.296

Cap5-10ug/mL Capreomycintranslation

-0.401

Rox10-50 ug/mL Roxithromycintranslation

0.539

SM2-5 ug/mL Streptomycintranslation

-1.414

Tet5-10 ug/mL Tetracyclinetranslation

-0.069

Rif0.2-5ug/mL Rifampicintranscription

-0.309

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.570

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.681

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.282

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.261

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.203

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.822

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.253

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.766

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.321

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.201

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.468

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.289

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.918

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.039

KCN5-20 ug/mL Potassium cyaniderespiration

0.166

NaN30.2-2 mM Sodium aziderespiration

-1.216

Nigericin50 uM Nigericinrespiration

0.582

TRC10-150 ug/mL Triclosanrespiration

-0.098

TRZ10-25 ug/mL Thioridazinerespiration

4.102

Valinomycin0.5-10 uM Valinomycinrespiration

0.852

ZnSO42 mM ZnSO4respiration

2.119

menadione6-10 ug/mL Menadionerespiration

-0.642

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.080

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.331

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.398

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.216

NRP_1Non-replicating persistence stage 1dosRassociated

0.111

Amp0.2mg/mL AmpicillincellWall

0.090

Cephalexin20-100 ug/mL CephalexincellWall

-0.011

Cerulenin0.32-5 ug/mL CerulenincellWall

0.057

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.142

EMB10-20 ug/mL EthambutolcellWall

-0.035

Eta12-40 ug/mL EthionamidecellWall

0.190

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.065

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.686

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.193

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.151

BZA0.12 mg/mL BenzamidearomaticAmides

-0.075

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.304

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.785

H2O24 mM hydrogen peroxideDNAdamaging

-0.400

Levo10 ug/mL LevofloxacinDNAdamaging

-0.539

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.985

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.173

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.231

UVUV-irradiationDNAdamaging

1.156

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.682

Antimycin12.5-50 ug/mL Antimycin A?

0.110

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.311

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.346

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.011

PA8240.2-2 ug/mL PA-824?

0.900

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.501

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.363

Verapamil50 uM Verapamil?

0.175

mercaptoethanol2 mM 2-Mercaptoethanol?

0.112

methoxatin10-20 ug/mL Methoxatin?